Ocugen, Inc.

Healthcare

NASDAQ:OCGN · NASDAQ Capital Market

Market Cap $413.00M Beta 2.21 P/E (TTM) -5.4

$1.21 -0.82%

-$0.01 today

52W Low $0.90High $2.73

Vol 3.71M · Avg 7.78M

EPS (TTM)-$0.22

Biotechnology

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

557.7%

avg 149.5%

ROIC

-278.6%

avg -112.4%

ROA

-155.9%

avg -97.8%

Analysis

ROE is currently the strongest return metric at 557.7% versus its period average of 149.5%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management

Name	Title	Compensation	Tenure	Age	Shares Owned	Ownership %
Shankar Musunuri	Co-Founder, Chief Executive Officer & Chairman	$1.26M	—	62	$4.96M	1.46%
Arun Upadhyay	Chief Scientific Officer and Head of Research & Development	$703,751.00	—	44	$306,197.00	0.09%
Huma Qamar	Chief Medical Officer	$644,027.00	—	42	$1.15M	0.34%
Ramesh Ramachandran	Chief Accounting Officer & Principal Accounting Officer	$504,925.00	—	58	$310,950.00	0.09%
Vijay Tammara	Chief Development Officer	$490,915.00	—	66	$42,578.00	0.01%
Uday Kompella	Co-founder & Independent Director	$61,875.00	—	59	$151,316.00	0.04%
Mohamed Genead	Interim Chief Medical Officer	—	—	—	—	—
Jyothy Pillai	Vice President & Head of Regulatory & Quality	—	—	—	—	—
Kristen Craft	Head of People & Culture	—	—	—	—	—
Rita Johnson-Greene	CFO & Principal Accounting Officer	—	—	49	$500,000.00	0.15%
Tiffany Hamilton	AVP & Head of Corporate Communications	—	—	—	—	—
Durgaprasad Annavajjula	Vice President, Head of Program Management & Chief of Staff	—	—	—	—	—
Paul Staid	Executive Vice President of Operations	—	—	—	—	—
John Kouch	General Counsel	—	—	—	$25,000.00	<0.01%